IRIS
BUONERBA, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.330
EU - Europa 880
AS - Asia 814
SA - Sud America 71
AF - Africa 51
OC - Oceania 4
Totale 3.150
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.306
SG - Singapore 413
IT - Italia 278
HK - Hong Kong 156
NL - Olanda 124
CN - Cina 122
RU - Federazione Russa 106
DE - Germania 90
BR - Brasile 63
VN - Vietnam 56
GB - Regno Unito 54
FI - Finlandia 52
UA - Ucraina 50
CI - Costa d'Avorio 39
IN - India 38
IE - Irlanda 37
SE - Svezia 31
CA - Canada 22
FR - Francia 19
AT - Austria 14
BE - Belgio 8
ZA - Sudafrica 8
CZ - Repubblica Ceca 5
AR - Argentina 4
DK - Danimarca 4
IR - Iran 3
MA - Marocco 3
NZ - Nuova Zelanda 3
UZ - Uzbekistan 3
BD - Bangladesh 2
BG - Bulgaria 2
CH - Svizzera 2
EC - Ecuador 2
KZ - Kazakistan 2
MX - Messico 2
NP - Nepal 2
PK - Pakistan 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
ES - Italia 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
MD - Moldavia 1
NG - Nigeria 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 3.150
Salva come PNG Salva come JPEG
Città #
Singapore 219
Chandler 207
Hong Kong 156
Amsterdam 111
Naples 100
Ashburn 95
Santa Clara 89
Millbury 59
Dong Ket 56
Beijing 39
Lawrence 38
Boston 36
Napoli 34
Des Moines 33
Princeton 27
Helsinki 24
Nanjing 22
Wilmington 21
Ottawa 16
Washington 16
Seattle 15
Nuremberg 12
Dallas 11
Dublin 11
Los Angeles 10
Fairfield 8
Falkenstein 8
Hebei 8
Milan 8
Nanchang 8
Rome 8
Düsseldorf 7
Frankfurt am Main 7
Caserta 6
Jacksonville 6
Norwalk 6
Redwood City 6
Shenyang 6
São Paulo 6
Vienna 6
Boardman 5
Changsha 5
Lauterbourg 5
Munich 5
Portsmouth 5
Toronto 5
Woodbridge 5
Brno 4
Brussels 4
Courcelles 4
Dearborn 4
Houston 4
Kronberg 4
Moscow 4
Shanghai 4
Tianjin 4
Abidjan 3
Ann Arbor 3
Ardabil 3
Augusta 3
Aversa 3
Catania 3
Falls Church 3
Guarulhos 3
Lappeenranta 3
New York 3
Pune 3
Tashkent 3
Agadir 2
Auckland 2
Dalmine 2
Kathmandu 2
Kochi 2
Kunming 2
Latina 2
Locate di Triulzi 2
Manassas 2
Monmouth Junction 2
Novo Hamburgo 2
Pescara 2
Piana 2
Pontedera 2
Rio de Janeiro 2
Rochdale 2
Rovereto 2
Saint-Fons 2
Salerno 2
Shenzhen 2
The Dalles 2
Tronzano Vercellese 2
Zhengzhou 2
Acerra 1
Afragola 1
Alba 1
Almaty 1
Alpestre 1
Amman 1
Antônio Gonçalves 1
Arroio Grande 1
Baghdad 1
Totale 1.723
Salva come PNG Salva come JPEG
Nome #
Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up 155
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 77
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 68
A comprehensive outlook on inracerebral therapy of malignant gliomas 66
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 64
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 62
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis 60
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 60
A third-line sorafenib aftrer sequential therapy with sunitinib and mTOR inhibitors in methastatic renal cell carcinoma 59
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 57
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme? 56
The use of chest ultrasonography in suspected cases of COVID-19 in the emergency department 56
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 54
Biomarkers in localized prostate cancer 54
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 53
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 53
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 52
Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT Comparison. 51
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer 51
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 50
Castration-resistant prostate cancer: current and emerging treatment strategies 49
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 49
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 49
A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient. 48
Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study 48
The tnfrsf13c h159y variant is associated with severe covid-19: A retrospective study of 500 patients from southern italy 48
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 48
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 47
Efficacy of rituximab in gastric diffuse large B cell Lymphoma patients. 46
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review 46
Locally advanced paranasal sinus carcinoma: A study of 30 patients 46
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 46
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 45
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 44
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 44
Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review 44
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 44
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 44
Phase II Study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 43
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): A population-based study 43
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 42
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 42
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 41
Lack of cumulative toxicity associated with cabazitaxel use in prostate cancer 41
The emerging role of obesity, diet and lipid metabolism in prostate cancer 41
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic 41
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 41
Liquid biopsy in bladder cancer: State of the art and future perspectives 41
COVID-19 and prostate cancer: A complex scenario with multiple facets 41
Imatinib mesylate in thymic epithelial malignancies. 40
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 40
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities 39
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 38
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 38
Regulatory noncoding and predicted pathogenic coding variants of ccr5 predispose to severe covid-19 38
Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation 37
Urologic malignancies: advances in the analysis and interpretation of clinical findings 36
Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy 35
An adjusted indirect comparison of everolimus andsorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples 33
Ten-year adjuvant treatment with somatostatin analogs in a patient with atypical carcinoid of the lung. 32
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients 32
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone 29
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 28
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting 28
Instant messaging in cancer care 27
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 27
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 26
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 24
Preoperative Albumin-to-Alkaline Phosphatase Ratio as an Independent Predictor of Lymph Node Involvement in Penile Cancer 22
Fascin-1 and its role as a serological marker in prostate cancer: A prospective case-control study 22
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond 17
Current imaging evaluation of tumor response to advanced medical treatment in metastatic renal-cell carcinoma: Clinical implications 14
The Impact of Flavonoid Supplementation on Serum Oxidative Stress Levels Measured via D-ROMs Test in the General Population: The PREVES-FLAVON Retrospective Observational Study 11
Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL 8
Totale 3.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 0 0 0 0 0 18 36 7
2020/2021192 7 2 10 6 14 22 10 1 14 11 23 72
2021/2022556 20 6 10 2 3 5 8 13 144 45 159 141
2022/2023611 66 25 33 15 73 62 8 63 100 112 46 8
2023/2024442 12 67 85 36 25 55 3 62 2 6 58 31
2024/20251.213 101 94 3 32 106 109 235 141 198 194 0 0
Totale 3.271